MedTrace Logo

Vitamin D for the Treatment of Severe Asthma

NCT00712205 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2009-08-13

No results posted yet for this study

Summary

The investigators want to test the hypothesis, that vitamin D3 improves pulmonary function and quality of life in patients with asthma relatively resistant to glucocorticoids.

Conditions

Interventions

DRUG

Placebo

once daily 1mcg Placebo for 28days followed by crossover treatment

DRUG

Calcitriol

once daily 1mcg Calcitriol / Placebo for 28days followed by crossover treatment

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    collaborator OTHER

  • Kantonsspital Baselland Bruderholz

    lead OTHER

Principal Investigators

  • Albrecht Breitenbuecher, MD · Kantonsspital Baselland Bruderholz

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • Switzerland

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00712205 on ClinicalTrials.gov